| Name | Title | Contact Details |
|---|
Founded in March 2019, the objective of The Fertility Partners (“TFP”) is to be a world class business partner of choice for leading North-American IVF clinicians with the goal of achieving global best clinical outcomes, an international reputation for excellence and exceptional patient experiences. TFP will provide partner clinics with back office support and a collaborative synergistic medical-scientific, professional and business environment.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
Midwest Health Plan is a Dearborn, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Clinical Resources Group is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.